Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (16 Jan 2026): | 844.90 |
| Day range: | 840.08 / 849.75 |
| Change abs./rel.: | 6.12 / 0.73% |
| Year range: | 544.13 / 849.75 |
| Name | Number of shares |
|---|---|
| BAYER AG | 0.624132 |
| RECORDATI SPA | 0.663004 |
| GENMAB A/S | 0.457756 |
| HALEON PLC | 4.208757 |
| SANOFI SA | 0.451737 |
| GSK PLC | 2.122687 |
| SANDOZ GROUP AG | 0.340632 |
| GALDERMA GROUP AG | 0.118127 |
| UCB SA | 0.348672 |
| ASTRAZENECA PLC | 0.634007 |
| NOVARTIS AG | 0.322145 |
| NOVO NORDISK A/S | 0.738589 |
| ROCHE HOLDING AG | 0.36428 |
| IPSEN SA | 0.594982 |
| MERCK KGAA | 0.164374 |